# Fulvestrant

NDC: 43598-262
Generic name: Fulvestrant
Labeler / Manufacturer: Dr.Reddy's Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20231231

FDA application: ANDA209246

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-262"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-262
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fc17ba3-83c7-a2b4-8a75-6a0cb1e07682